Summary
Kotak Institutional Equities believes the market is undervaluing ITC's tobacco business, suggesting it is priced at around 11X its one-year forward earnings. The brokerage argues that a vertical split of ITC could unlock significant value for shareholders by separating the tobacco and non-tobacco entities.